I was going to start a new thread called ‘global
best in class multi $bn segment medical device’ or something then realised I couldn’t be arsed.
seriously iTrack advance is taking over the last few weeks. All ON TOP of existing growth rate primarily driven by US
- multiple Latin American / South American surgeons going to workshop ma
- Portugal introduction to public health system
- more German surgeons (below)
- introduction to more fields hospital UK home hospital of national eye health clinical director (refer to my previous posts on this)
- new approvals in train for Asia
- new sales reps in Canada
- US growth off the charts and attracting best in class sales reps to push harder
- sales reps and distribution in UAE / Dubai
how can this stay down for the next 6 months. Answer is IT WONT…. Bring me more sugar baby. They are excited you can tell.
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-176
-
- There are more pages in this discussion • 332 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.10M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 21.0¢ | $45.70K | 217.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2722 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 57356 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| EYE (ASX) Chart |